Madrigal Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone, and welcome. I'm Pradyumna from JPMorgan's healthcare team. Thank you for joining us for the call Madrigal Pharmaceuticals presentation today. Madrigal has been one of the most consequential companies in the metabolic and liver disease over the last few years. And today, we're pleased to be joined by Bill Sibold, the Chief Executive Officer; Dr. David Soergel, Chief Medical Officer; and Mardi Dier, the Chief Financial Officer.
Bill and David will speak for about 20 minutes, after which we'll move into a live Q&A session. At that point, we'll also be joined by Mardi Dier. With that, Bill, I'll turn it over to you.
Thank you, Prad, and thank you to JPMorgan for having us here. This is always a great way to kick off the year and to provide a progress update for how we're doing. I'll start by saying that this is an exciting time at Madrigal. You've often heard me say that I think this is the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
